NKGen Biotech to Present on Troculeucel for Neurodegenerative Diseases at 4th Great Bay Cell and Gene Therapy Forum

Go back to NKGen Biotech to Present on Troculeucel for Neurodegenerative Diseases at 4th Great Bay Cell and Gene Therapy Forum
(NASDAQ: NKGN) Delayed: 0.19 --0 (-0%)
Previous Close $0.19    52 Week High
Open $0.19    52 Week Low
Day High $0.19    P/E N/A 
Day Low $0.19    EPS
Volume 33,244